Formoterol Fumarate Patent Expiration
Formoterol Fumarate is Used for managing symptoms and improving lung function in individuals with chronic obstructive pulmonary disease. It was first introduced by Novartis Pharmaceuticals Corp
Formoterol Fumarate Patents
Given below is the list of patents protecting Formoterol Fumarate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Foradil | US6488027 | Powder inhaler |
Mar 08, 2019
(Expired) | Novartis |
| Foradil | US6887459 | Aerosol composition comprising formoterol |
Nov 28, 2020
(Expired) | Novartis |
| Perforomist | US6667344 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US6814953 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US7348362 | Bronchodilating β-agonist compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US7462645 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US8623922 | Bronchodilating Beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US9730890 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
Try Our Curated Drug Screens
Formoterol Fumarate Generics
Several generic applications have been filed for Formoterol Fumarate. The first generic version for Formoterol Fumarate was by Teva Pharmaceuticals Usa Inc and was approved on Jun 22, 2021. And the latest generic version is by Micro Labs Ltd and was approved on Jun 26, 2024.
Given below is the list of companies who have filed for Formoterol Fumarate generic.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Nov 22, 2021 |
2. LUPIN
Lupin Inc has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Lupin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Aug 22, 2022 |
3. MANKIND PHARMA
Mankind Pharma Ltd has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Mar 22, 2023 |
4. MICRO LABS
Micro Labs Ltd has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Jun 26, 2024 |
5. RITEDOSE CORP
The Ritedose Corp has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Ritedose Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Nov 25, 2022 |
6. TEVA PHARMS USA INC
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Jun 22, 2021 |
7. WILSHIRE PHARMS INC
Wilshire Pharmaceuticals Inc has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Wilshire Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Dec 13, 2022 |